National Guidelines For Cardiovascular Diseases Management

Objectives

Provide national guidance for prevention, risk reduction, standardised diagnosis, treatment, referral, rehabilitation, follow-up and palliative care for cardiovascular diseases across Kenya’s health system.[1][2]The guideline addresses behavioural risks, hypertension, coronary and cerebrovascular disease, heart failure, rheumatic and congenital heart disease, venous thrombo-embolism, cardiovascular conditions in special populations, and palliative care.[1][3]

• Reduce cardiovascular risk, disease progression, complications, morbidity and mortality through population-wide and individual risk-based prevention.[4][5][6]
• Prevent tobacco use, unhealthy diet, physical inactivity, harmful alcohol use, overweight and obesity through health promotion, counselling and pharmacological support where needed.[7][4][8]
• Apply primordial, primary, secondary and tertiary prevention, spanning awareness, screening, early detection, treatment, rehabilitation and palliative care.[4]
• Use World Health Organization and International Society of Hypertension AFRO E charts to estimate 10-year cardiovascular risk and target care according to risk level.[4][9]
• Strengthen early detection and control of hypertension, with treatment generally aiming for blood pressure below 140/90 mmHg to reduce stroke, coronary heart disease, chronic kidney disease, heart failure and death.[10][11]
• Improve rapid recognition, triage, diagnosis, transfer and treatment for acute coronary syndromes and stroke, including timely electrocardiography, thrombolysis where indicated, imaging, specialist assessment and referral.[12][13][14]
• Advance secondary prevention and rehabilitation after ischaemic heart disease and stroke through risk-factor control, medicines, health education, physical activity, diet, medication adherence and tobacco cessation.[15][16]
• Prevent acute rheumatic fever and rheumatic heart disease through early treatment of group A streptococcal infection, regular secondary prophylaxis and management of complications.[17][18]
• Reduce avoidable suffering by integrating multidisciplinary palliative care throughout cardiovascular illness, using early holistic assessment and treatment of physical, psychosocial and spiritual needs.[3]

Implementation

Deliver cardiovascular care through a tiered, referral-based model linking community action, primary care, county referral services and specialised national-level care.[1][2][19]Community Health Volunteers assess risk and promote prevention, while increasingly specialised facilities provide diagnosis, treatment, rehabilitation, surgery, critical care and advanced cardiac interventions.[1][2]

• Train and equip Community Health Volunteers to assess cardiovascular risk using blood-pressure machines, glucometers, anthropometric tools and risk charts, and link households with health facilities through community health extension workers.[1]
• Deliver public education through posters, vernacular radio, barazas, community health forums, dialogue and action days, including awareness of cardiovascular risk factors, sore throats, stroke symptoms and tobacco cessation.[1][17][20]
• Provide lower-level services for risk assessment, screening, lifestyle counselling, uncomplicated hypertension and diabetes management, treatment initiation, referral and follow-up.[1][21]
• Equip higher-level facilities with specialised personnel, laboratory capacity, electrocardiography, echocardiography, catheterisation, surgery, telemedicine, critical care and rehabilitation capacity according to service level.[2][21]
• Establish coordinated emergency pathways for chest pain and stroke, including equipped ambulances, expedited triage, electrocardiography, specialist links, resuscitation capability, acute care teams and transfer arrangements.[22][12][14]
• Use multidisciplinary care for heart failure, cardiac rehabilitation, palliative care, pregnancy-related cardiac conditions and high-risk delivery planning, involving relevant cardiac, obstetric, neonatal, anaesthetic and other clinical teams.[23][24][25][3]
• Support rheumatic heart disease services across six levels through community education, surveillance, sore-throat management, prophylaxis, imaging, referral, surgery, interventional cardiology, trained health workers, essential medicines and data tools.[26]
• Strengthen congenital heart disease screening through newborn auscultation and pulse oximetry, prompt clinical review of failed tests, paediatric assessment and specialist referral.[27][28]
• Integrate cardiovascular screening and management into services for people with diabetes, people living with HIV, chronic kidney disease, older people, athletes and pregnant women, adapting treatment to comorbidities, drug interactions and clinical risk.[29][30][31][32]
• Undertake population and facility mapping of cardiovascular burden, investigate determinants and outcomes, and assess care quality across counties as priority research activities.[21]

Contributors include the Ministry of Health, county governments, professional associations, universities, health facilities, non-governmental organisations and international partners, including the Kenya Cardiac Society, Kenya Pediatric Association, University of Nairobi, World Health Organization and NCD Alliance-Kenya.[33]The available text does not specify a document-level budget, financing plan, formal implementation timetable, programme-wide indicator framework, reporting system or accountability mechanism.[34][21][33]

Monitoring & Evaluation

Monitoring is predominantly clinical and condition-specific, centred on repeated risk assessment, diagnostic testing, treatment safety, symptom review and referral. The source does not establish a unified national monitoring and evaluation framework, routine reporting system, common indicator set, evaluation timetable, surveillance architecture or formal accountability mechanism for the cardiovascular disease guideline.[1][21][33]

• Assess cardiovascular risk using World Health Organization and International Society of Hypertension AFRO E charts, incorporating age, sex, systolic blood pressure, cholesterol, smoking and diabetes status; reassess annually for people with diabetes and every 3–6 months for high- or very-high-risk patients.[9][5]
• Monitor hypertension through confirmed measurements on at least three occasions, lifelong blood-pressure follow-up, four-weekly review during treatment initiation, and four- to six-monthly review once target blood pressure is reached.[6][35]
• Use the 2015 Kenya STEPS survey as a population-level reference for elevated blood pressure or treatment, screening, awareness, treatment and control, while recognising that the guideline does not define an ongoing national hypertension surveillance system.[36]
• Track treatment safety and response through lipid profiles for statin treatment, renal function and electrolytes during heart-failure treatment, international normalised ratio or activated partial thromboplastin time during anticoagulation, and blood-pressure, creatinine and potassium monitoring for people with diabetes, HIV or chronic kidney disease.[37][23][38][39][30][31]
• Apply time-critical process standards for acute care, including electrocardiography within 10 minutes of hospital arrival for acute coronary syndrome and thrombolysis for ST-elevation myocardial infarction within 30 minutes of diagnosis.[12][13]
• Use clinical classification and diagnostic tools to guide management, including New York Heart Association and American College of Cardiology/American Heart Association heart-failure classifications, HEART scoring for acute coronary syndrome, Wells-type prediction rules for pulmonary embolism, and structured stroke severity assessment.[40][41][42][43][14]
• Conduct surveillance and case identification for rheumatic fever and rheumatic heart disease through community referral of children with fever or sore throat, epidemiological surveillance at service levels two to five, data-collection tools, laboratory testing and patient registration where available.[44][26]
• Implement specified screening protocols for congenital heart disease, including newborn pulse oximetry after 24 hours of life, repeat testing for borderline results and clinical consultation before discharge after failed screening.[28]
• Monitor pregnancy-related cardiovascular risks through blood pressure, pulse, heart sounds and oxygen saturation where indicated at antenatal visits, with serial assessment for hypertensive disorders and maternal-fetal monitoring for pre-eclampsia.[32][24][45][46]
• Strengthen evidence generation through population and facility mapping of cardiovascular disease burden, research on determinants and outcomes, qualitative assessment of care quality across counties, and improved venous thromboembolism health-information systems.[21][47]

Costing & Financing

No budget, costed implementation plan, funding source, funding gap, financing allocation, resource-mobilisation mechanism or quantified economic assumption is specified across the supplied sections. The guideline identifies substantial workforce, medicine, diagnostic, imaging, referral, emergency, surgical and information-system requirements, but does not attach financial values to these inputs.[2][12][26][48]

• Recognise that cardiovascular diseases can cause costly diagnosis and management, premature death, catastrophic health expenditure and high out-of-pocket spending.[34][1]
• Prioritise resource-sharing arrangements for ischaemic heart disease, including shared ambulances, critical-care areas, catheterisation laboratories, diagnostic services, rehabilitation centres, specialist staff and secure medical records, to ease pressure on limited resources.[49]
• Use secondary prophylaxis with benzathine penicillin G for rheumatic heart disease, identified as clinically effective and cost-effective at community and population levels, although no monetary estimate or economic model is provided.[18]
• Recognise prevention or delay of symptomatic heart failure through modifiable risk-factor reduction as cost-beneficial, with potential to reduce overall healthcare costs.[50]
• Use sodium and fluid management in heart failure as a cost-effective means of avoiding avoidable hospitalisation and reducing mortality, while patient education is associated with lower healthcare use and cost.[23]
• Consider cardiac resynchronisation therapy, with or without a defibrillator, as providing significant cost-benefit for selected patients with reduced left-ventricular ejection fraction and prolonged QRS duration; no quantified estimate is supplied.[51]
• Recognise echocardiography as widely available and low cost for paediatric heart-failure assessment, but note that no budget or financing strategy accompanies this statement.[52]
• Recognise that palliative care may reduce overall disease costs and inpatient days, without specified expenditure, financing or savings estimates.[3]
• Recognise that chronic kidney disease creates a major economic burden for individuals, families and health systems, particularly in advanced disease and when cardiovascular disease coexists.[53]